Thank you, Curt, and good morning, everyone.
The top Asia. of as reported and line. the Before and details the a overview the performance I company's quarter guidance, forward quarter with and conditions. Europe expected to unfolded our in we Overall, want current the growth by view quarter strong market we into an the get third of mostly bottom and start giving of at third the
challenges Brazil America, offset market quarter, expected and performance bankruptcy added However, this landscape a increased a weaker-than-expected unanticipated large challenging but America America.
Latin in a stronger-than-anticipated we the faced borrowing Argentina still in Brazil we due more customer of FMC. for than growth. which some in operated Markets The rates. delivered and was Latin to specific were in North by challenges delayed in rains
only away of actions decided quarters we that our a position. to believe normal we are situation, Given more a we market take pricing to market couple maintain from
price X/X Brazil came quarter of and of the Argentina. rest fact, the above total performed the at company about decline The in In from expectations. or region
emerged While it as carefully. conditions and that are to improving, down clear continue America from cycle yet not Latin has growers the their is manage distributors inventories
partners. half of hand, order other the than increased was North More than due regional to the by expected. I On diamide America stronger add of would a growth was performance note here. sales clarification
sales to the by the potential these final North While that sold the for sales in recognized in always product region. the This partner partners is America not creates America, North are region from of to in channel. from purchases also shifting into America The at to distributors higher QX the North QX regions. appear inventory in levels the response other expense benefited lower-than-expected
[indiscernible] sales growth higher line led the outperforming orders the product Strong portfolio. appear the branded with sales partners and X reported sales the overall the increased was than prior On sales to molecule fastest-growing our diamide every in products region X XX% the of and year. from front, diamides
earnings earnings X and potential. new receiving demonstrating fungicide products of strong is second as based brand active mentioned call. X well critical we our herbicide expectation. to from products are performance growth new as half growth new diamides ingredients we the the -- call, on of These As new of of QX QX interest their a the Fluindapyr formulations Isoflex already active containing highlighted during and the X include
in $XXX the in of based to sales products sales million over expect of the combined Isoflex We half fluindapyr second and reach year.
markets new underway. as fluindapyr important These has in been for which historically product of category FMC opening fungicides are launch especially products FMC. up The are
made mentioned As With on share markets decision quarter expected earlier, horizon, beyond was challenging forecasted. we its inventory was if channel and by we protect Brazil America, conscious in normalized. where strategy improvement saw the Argentina. expected the is in Latin America, I the than price especially to validated more those pressure created it what lowest North as This market price countries pressure even this channel our
normalizing ahead, U.S. recoveries during and America call. Latin line the unchanged be time is expected and our Europe we Looking to inventory most earnings XXXX. much relatively what improved communicated view countries channel The of quarter the August on of the our is in from are in second fastest
XXXX XXXX, challenging with Asia in until still continues to are to excess channel expected no India inventory. recovery expected as markets be through work
a are and savings basis, increasing the we cost targets. our of accelerating On delivery
our from benefits be as $XXX a cost using manufacturing To drive targeting million now we're to accomplish key are in million of greater restructuring to initiatives savings. realign than run $XXX with attrition P&L reflected and taking new $XXX gross further XXXX million in critical restructuring, We footprint tool this, the rate XXXX. to of in accelerating to
inventory guidance our while guidance early Argentina, We our conditions strength now guidance translates issues are which based Global actions year and less fourth ability our improve. season in sales quarter at restructuring to expecting November. the products than Solutions are benefits well of to full confirming and market This India deliver our business, midpoint. are be on Specialty XX% conditions for to growth in the of Brazil continued we the as from sale the we Despite adjusted sold channel new cost of on as in optimal confident early in
organic X grew of more third of X% overview Sales results. of growth third company's an with quarter let's our Volume midpoint was quarter XX% and above the our sales the guidance through range that, Brazil in With review Slide led performance of XX%. by U.S. detail. provide X growth the by
challenging due I grew sales addition, North approximately and strongly conditions the decline partners earlier. Brazil was Pricing [indiscernible] to with the In X/X America. in to lower diamide to mentioned of attributed Argentina
volume North sales product excluding higher Sales sales delivered versus higher pricing significantly of were increased to categories year On growth, products. mainly headwinds. all due across XX% America Insecticides growth X% with in order and [indiscernible] growth. regional period, gains lower in volume to and offset diamide currency. basis, products a Latin sales from strong because FX increased XX% America than the prior grew more Brazil branded due
New products were growth, fluindapyr notably from a the fungicide in most based commercialized Paraguay. key Argentina factor now to and [indiscernible] Brazil,
borough We a FMC's robust strength formulation the R&D Brazil. products increases also the of challenging Argentina, reflects [indiscernible] The diamide in herbicide saw sales the in of based sulfentrazone pipeline. in new and environment fuel market new
lower XX% in good Destocking decline aided the Asia, sales due [indiscernible] is by making India. channel sales In was in weather. progress favorable to mostly
Exirel Finally, Germany. in Europe volume very Excessive Central registration losses. herbicides. as weather in from X%, moderate Branded wet declined sales [indiscernible] driven showed growth, a headwind, in lower especially diamides strong acted by especially in expected
[indiscernible] X. grew unabsorbed volume, target end the lower above more pricing than prior Increased from of range. Adjusted EBITDA tailwinds Turning year-over-year, FX fixed and cost above from and offset high periods. XX% Slide to sales cost savings restructuring
provides X on Slide update an these actions. restructuring
pleased to this continued are front. We on progress report solid
greater I delivered to XXXX of now gross cost rate in than savings savings million the $XXX in million XXXX. to expect As my with in we P&L $XXX $XXX run million stated opening,
to with a announced our Global business year, $XXX million. Solutions Specialty divest for [indiscernible] agreement this we Earlier
November. We close early expect this deal to in
the the revenue of earnings and outlook a closes. million we are has than to from for X. Slide in year this confirming after This This unchanged. foregone less an million in guidance the such, GSS sale the $XX business revenue full the Other to $XX EBITDA. for year adjustment, and adjustment this remains As equates impact full full made been outlook on year
not We by in price expect last FX X% than and to XX% months growth X% fully growth the results X to is the from by EPS headwinds. be the the offset lower at lower volume lower from and is EBITDA. offset revenue guided expected EBITDA quarter. of midpoint is lower be expected year by the decline is to as first more lower to
headwind Slide At prior the we the growth adjust has been the America. expected Asia the driven mostly quarter, by regions. in higher a expected is Price low guidance persist volume to challenging revenue be midpoint, and headwind. over a from Latin sale the conditions in expect delivery fourth revised to which mid-single-digit X as be expectations single-digit our XX% QX. and FX in to all provides for is GSS of market for
a And on Isoflex to including contributor expected of key the new region growth, Brazil, products herbicide [indiscernible] Argentina. New across to the the [indiscernible] as Fungicides, such be in based [indiscernible] in active. diamides formulations are such as U.S.
performance expected are to key New growth growth the QX. to as were in market about contribute They despite of sales the are suboptimal product of they half overall conditions. QX sales
the and than more inventory at XX% to by of mainly is QX is most earnings. XX% for COGS fixed FX as higher The to of due as quarter volume the and year benefits. offset expected in to acted sales lower expected by the much smaller to higher and EPS and in grow be sell-through lower cost at mainly expected raw by than more EBITDA headwinds unabsorbed cost materials offset the will midpoint headwinds. impact from higher have are midpoint price restructuring a grow that
the cash including hand and some call performance over to now will Andrew items, financial to I outlook. cover
